BrainsWay Announces $3 Million Investment in Radial Health, Inc.
BURLINGTON, Mass. and JERUSALEM, July 20, 2026 — BrainsWay Ltd. (NASDAQ & TASE: BWAY), a leader in advanced noninvasive brain stimulation technologies, has made a $3 million minority equity investment in Radial Health, Inc., supporting a network of Brain Medicine clinics. This investment is part of Radial’s Series A financing, alongside notable investors such as General Catalyst and JSL Health Capital.
About Radial Health
Radial focuses on developing clinical infrastructure and AI-guided support for delivering non-invasive brain treatments like Deep TMS™. This financing aims to explore growth opportunities, including potential mergers and acquisitions.
Statements from Leadership
Hadar Levy, BrainsWay’s CEO, remarked, “We are pleased to announce our strategic investment in Radial, enhancing access to advanced psychiatric care.” John Capecelatro, Radial’s CEO, expressed gratitude for the support, emphasizing the importance of this investment in building a national mental health care platform.
About BrainsWay
BrainsWay is at the forefront of noninvasive neurostimulation treatments, with FDA-cleared indications for conditions including major depressive disorder and smoking addiction. Founded in 2003, the company continues to lead through rigorous scientific research.
For more information, visit BrainsWay’s website.
Forward-Looking Statements
This release contains statements that may be deemed forward-looking. Actual results could differ, influenced by various factors, including regulatory challenges and market conditions.
Contacts
-
Ido Marom
CFO, BrainsWay
Ido.Marom@BrainsWay.com -
Jeff Warren
LifeSci Advisors LLC
jwarren@lifesciadvisors.com
Source: (GLOBE NEWSWIRE)
